| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0000000000000132 |
| P698 | PubMed publication ID | 24798311 |
| P2093 | author name string | Robert A Montgomery | |
| Andrea A Zachary | |||
| Mary S Leffell | |||
| Mary Carmelle Philogene | |||
| Paul Sikorski | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 660-665 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Differential effect of bortezomib on HLA class I and class II antibody | |
| P478 | volume | 98 |
| Q33437712 | Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work? |
| Q90730885 | Antibody-Mediated Rejection Treatment With Bortezomib in Renal Transplant Recipients: A Single-Center 24-Month Follow-up Case Report |
| Q52401610 | Antibody-mediated rejection: New approaches in prevention and management. |
| Q30277267 | Approach to the Highly Sensitized Kidney Transplant Candidate |
| Q39018530 | Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study |
| Q41495990 | Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection |
| Q38364329 | Donor HLA-specific Abs: to BMT or not to BMT? |
| Q39265221 | Donor-Specific Antibodies in Kidney Transplant Recipients |
| Q50858859 | Effectiveness of Bortezomib in a Patient With Acute Rejection Associated With an Elevation of Donor-Specific HLA Antibodies After Small-Bowel Transplantation: Case Report |
| Q89472835 | HLA in transplantation |
| Q52793674 | Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings. |
| Q36240178 | The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation. |
Search more.